Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 27, 2023

Prognosis of Single and Multiple TP53 Abnormalities Differs in Treatment-Naïve Patients With High-Count MBL and CLL

Blood Advances


Additional Info

Disclosure statements are available on the authors' profiles:

Blood Advances
Differential prognosis of single and multiple TP53 abnormalities in high count MBL and untreated CLL
Blood Adv 2023 Mar 06;[EPub Ahead of Print], R Griffin, JE Wiedmeier-Nutor, SA Parikh, CE McCabe, DR O'Brien, NJ Boddicker, G Kleinstern, KG Rabe, L Bruins, S Brown, C Bonolo de Campos, W Ding, JF Leis, PJ Hampel, TG Call, D Van Dyke, NE Kay, JR Cerhan, H Yan, SL Slager, E Braggio

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading